Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 46-6548416 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To support the research and development of treatments and cures for complications related to neurofibromatosis type 1.
Total Revenue
$581K
FY2024
Total Expenses
$137K
FY2024
Net Assets
$809K
Program Ratio
100.0%
expenses on programs
Employees
0
Volunteers
—
Board Members
10
Voting
2
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.